Brian Culley

Company: Lineage Cell Therapeutics

Job title: Chief Executive Officer

Seminars:

A Further Spotlight on OpRegen – A RPE Transplant for Dry AMD with GA 11:00 am

Reiterative how a transplant of RPE cells can be both robust and endured by patients with dry-AMD Understand further the benefits of OpRegen RPE cells in specific patients with dry-AMD, as well as primary indication of RPE-photoreceptor complex regeneration (GA reduction) Evaluate how RPE cell suspensions can be reasonably scaled to marketable quantitiesRead more

day: Track 2 Day 2 AM